Bio Protocol vs Izumi Finance — how do they compare? Bio Protocol trades at Rp438.26 (market cap Rp997,43M, Rp162,4M 24h volume), while Izumi Finance trades at Rp26.85 (market cap Rp32,06M, Rp254,85jt 24h volume). The key difference: Bio Protocol is far larger — about 31.1× Izumi Finance's market cap, and Bio Protocol's circulating supply is 2,3B / 3,3B BIO (69%) versus 787,4M / 2B IZI (40%) for Izumi Finance. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 18 Days and Izumi Finance for 11 Days on average.
| BIO | IZI | |
|---|---|---|
Market Cap | Rp997,43M | Rp32,06M |
Volume (24h) | Rp162,4M | Rp254,85jt |
Circulating Supply | 2,3B / 3,3B BIO (69%) | 787,4M / 2B IZI (40%) |
Typical Hold Time | 18 Days | 11 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp438.8 with a market cap of Rp996.68M, showing neutral technical signals overall. The token is currently testing the pivot point at Rp440, with immediate support at Rp430 and resistance at Rp454. With 69% of max supply in circulation and an average hold time of 18 days, the token exhibits moderate liquidity. Recent technical indicators show mixed signals with bearish moving averages but neutral oscillators.
Outlook remains neutral with key opportunities in potential breakout above Rp454 resistance. Major risks include low market cap vulnerability to volatility and limited fundamental developments. Investors should monitor trading volume patterns and broader crypto market sentiment for directional cues.
Izumi Finance (IZI) shows limited market activity with a modest market cap of Rp32.06M and 40% token circulation. The token exhibits typical crypto volatility with an average hold time of 11 days, indicating short-term trading patterns. No recent protocol updates or significant ecosystem developments have been observed, suggesting quiet network activity.
Overall outlook remains cautious due to low liquidity and limited market presence. Key opportunities include potential ecosystem growth if development resumes, while major risks include high volatility, regulatory uncertainty, and low trading volume affecting price stability.
What Pluang investors did over the last 30 days
No sentiment data available yet.
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →Izumi Finance provides Programmable Liquidity as a Service (LaaS) on Ethereum with Uniswap V3 and plans to expand to multiple chains with integrated DEXs. This service allows liquidity providers to earn extra liquidity mining rewards and trading fees. It also helps protocols attract and maintain liquidity effectively. Izumi improves incentive distribution through its LiquidBox, allowing rewards to be allocated within specific price ranges.
Read more on IZI →